Summit Trail Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,170
Closed -$206K 1335
2025
Q3
$206K Buy
2,170
+161
+8% +$15.2K ﹤0.01% 1290
2025
Q2
$210K Sell
2,009
-1,627
-45% -$154K ﹤0.01% 1042
2025
Q1
$321K Buy
3,636
+508
+16% +$52.1K 0.01% 316
2024
Q4
$300K Sell
3,128
-876
-22% -$81.6K 0.01% 291
2024
Q3
$328K Buy
4,004
+11
+0.3% +$849 0.01% 519
2024
Q2
$344K Buy
3,993
+630
+19% +$50.9K 0.01% 444
2024
Q1
$275K Hold
3,363
0.01% 487
2023
Q4
$223K Buy
3,363
+115
+4% +$7.97K 0.01% 472
2023
Q3
$237K Buy
3,248
+8
+0.2% +$540 0.01% 454
2023
Q2
$205K Sell
3,240
-187
-5% -$10.8K 0.01% 480
2023
Q1
$201K Buy
+3,427
New +$208K 0.01% 389
2022
Q3
Sell
-3,686
Closed -$226K 392
2022
Q2
$226K Buy
+3,686
New +$236K 0.01% 325
2018
Q1
Sell
-17
Closed -$1K 979
2017
Q4
$1K Buy
+17
New +$842 ﹤0.01% 1809

Other funds holding HQY

Summit Trail Advisors's HQY Position: Q4 2025 in Review

Summit Trail Advisors sold out of HealthEquity (HQY) in Q4 2025, closing a stake of 2,170 shares — an estimated $206K sold.

Summit Trail Advisors first reported a position in HQY in Q4 2017 and held it in 13 quarters. The position peaked at $344K in Q2 2024. 511 funds tracked by Wall St. Rank hold HQY as of Q4 2025.

  • Summit Trail Advisors reported no remaining HealthEquity position as of Q4 2025 after selling out during the quarter.
  • Summit Trail Advisors sold 2,170 HealthEquity shares in Q4 2025, an estimated $206K.
  • Summit Trail Advisors first reported a position in HealthEquity in Q4 2017 and held it in 13 quarters.
  • Summit Trail Advisors's HealthEquity position peaked at $344K in Q2 2024.
  • 511 funds tracked by Wall St. Rank held HealthEquity as of Q4 2025.

Based on Summit Trail Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.